{
    "nctId": "NCT02901106",
    "officialTitle": "Monitoring of Patients Followed for a Multiple Sclerosis and Treated by Dimethyl-fumarate SURV-SEP",
    "inclusionCriteria": "* patient 18 years old and more\n* with multiple sclerosis according to the criteria of Mac Donald 2010 : relapsing-remitting (RR), secondary-progressive (SP) or primary-progressive (PP)\n* for which treatment with dimethyl-fumarate has been prescribed\n* followed at the Rothschild Foundation in the Neurology Department\n* having given written consent to participation in the study\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "* pregnant or breastfeeding woman\n* patient with a measure of legal protection\n* subject unaffiliated insurance"
}